These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 14658978

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.
    Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
    [Abstract] [Full Text] [Related]

  • 3. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
    Revicki DA, Paramore LC, Sommerville KW, Swann AC, Zajecka JM, Depakote Comparator Study Group.
    J Clin Psychiatry; 2003 Mar; 64(3):288-94. PubMed ID: 12716270
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW.
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
    Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW.
    J Clin Psychiatry; 2002 Dec; 63(12):1148-55. PubMed ID: 12523875
    [Abstract] [Full Text] [Related]

  • 9. Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
    Gonzalez-Pinto A, Tohen M, Lalaguna B, Pérez-Heredia JL, Fernandez-Corres B, Gutierrez M, Micó JA.
    J Clin Psychopharmacol; 2002 Oct; 22(5):450-4. PubMed ID: 12352266
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Methodological proposals for the evaluation of the mood stabilizing effect of an antipsychotic drug].
    Boyer P.
    Encephale; 1999 Oct; 25(6):630-3. PubMed ID: 10668607
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic options in manic states].
    Azorin JM.
    Encephale; 2003 Oct; 29(Pt 2):S10-3. PubMed ID: 13677796
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treating bipolar depression.
    Shelton RC.
    J Fam Pract; 2003 Mar; Suppl():S14-7. PubMed ID: 12676079
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Olanzapine to treat the acute mania of bipolar disorder.
    Price PL.
    S D J Med; 2000 Dec; 53(12):523. PubMed ID: 11132516
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.